Does radiomics have added value in predicting the development of brain metastases in patients with radically treated stage III non-small cell lung cancer (NSCLC)?

L. Hendriks, S. A. Keek, A. Chatterjee, J. Belderbos, G. Bootsma, B. van den Borne, A-M. C. Dingemans, H. Gietema, H. J. M. Groen, G. Herder, C. Pitz, J. Praag, D. De Ruysscher, J. Schoenmaekers, H. J. M. Smit, J. Stigt, M. Westenend, H. Zeng, H. Woodruff, P. Lambin

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)S91-S91
Number of pages1
JournalAnnals of Oncology
Publication statusPublished - Apr-2022

Cite this